1
|
World Health Organization (WHO): Obesity
and Overweight. WHO, Geneva, 2021. https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight.
Accessed December 12, 2022.
|
2
|
Heymsfield SB and Wadden TA: Mechanisms,
pathophysiology, and management of obesity. N Engl J Med.
376:254–266. 2017.PubMed/NCBI View Article : Google Scholar
|
3
|
Ghaben AL and Scherer PE: Adipogenesis and
metabolic health. Nat Rev Mol Cell Biol. 20:242–258.
2019.PubMed/NCBI View Article : Google Scholar
|
4
|
Farmer SR: Transcriptional control of
adipocyte formation. Cell Metab. 4:263–273. 2006.PubMed/NCBI View Article : Google Scholar
|
5
|
Bray GA, Kim KK and Wilding JPH: Obesity:
A chronic relapsing progressive disease process. A position
statement of the World Obesity Federation. Obes Rev. 18:715–723.
2017.PubMed/NCBI View Article : Google Scholar
|
6
|
Bahmani M, Eftekhari Z, Saki K,
Fazeli-Moghadam E, Jelodari M and Rafieian-Kopaei M: Obesity
phytotherapy: Review of native herbs used in traditional medicine
for obesity. J Evid Based Complementary Altern Med. 21:228–234.
2016.PubMed/NCBI View Article : Google Scholar
|
7
|
Yoshioka M, St-Pierre S, Suzuki M and
Tremblay A: Effects of red pepper added to high-fat and
high-carbohydrate meals on energy metabolism and substrate
utilization in Japanese women. Br J Nutr. 80:503–510.
1998.PubMed/NCBI View Article : Google Scholar
|
8
|
Oh MJ, Lee HB, Yoo G, Park M, Lee CH, Choi
I and Park HY: Anti-obesity effects of red pepper (Capsicum
annuum L.) leaf extract on 3T3-L1 preadipocytes and high fat
diet-fed mice. Food Funct. 14:292–304. 2023.PubMed/NCBI View Article : Google Scholar
|
9
|
Boozer CN, Nasser JA, Heymsfield SB, Wang
V, Chen G and Solomon JL: An herbal supplement containing Ma
Huang-Guarana for weight loss: A randomized, double-blind trial.
Int J Obes Relat Metab Disord. 25:316–324. 2001.PubMed/NCBI View Article : Google Scholar
|
10
|
Suk S, Kwon GT, Lee E, Jang WJ, Yang H,
Kim JH, Thimmegowda NR, Chung MY, Kwon JY, Yang S, et al:
Gingerenone A, a polyphenol present in ginger, suppresses obesity
and adipose tissue inflammation in high-fat diet-fed mice. Mol Nutr
Food Res. 61(1700139)2017.PubMed/NCBI View Article : Google Scholar
|
11
|
Suk S, Seo SG, Yu JG and Yang H: A
bioactive constituent of ginger, 6-shogaol, prevents adipogenesis
and stimulates lipolysis in 3T3-L1 adipocytes. J Food Biochem.
40:84–90. 2016.
|
12
|
Mao QQ, Xu XY, Cao SY, Gan RY, Corke H,
Beta T and Li HB: Bioactive compounds and bioactivities of ginger
(Zingiber officinale roscoe). Foods. 8:1–21. 2019.PubMed/NCBI View Article : Google Scholar
|
13
|
Liu Y, Liu J and Zhang Y: Research
progress on chemical constituents of zingiber officinale roscoe.
Biomed Res Int. 2019(5370823)2019.PubMed/NCBI View Article : Google Scholar
|
14
|
Yücel Ç, Karatoprak GŞ, Açıkara ÖB, Akkol
EK, Barak TH, Sobarzo-Sánchez E, Aschner M and Shirooie S:
Immunomodulatory and anti-inflammatory therapeutic potential of
gingerols and their nanoformulations. Front Pharmacol.
13(902551)2022.PubMed/NCBI View Article : Google Scholar
|
15
|
Ali BH, Blunden G, Tanira MO and Nemmar A:
Some phytochemical, pharmacological and toxicological properties of
ginger (Zingiber officinale Roscoe): A review of recent
research. Food Chem Toxicol. 46:409–420. 2008.PubMed/NCBI View Article : Google Scholar
|
16
|
Baliga MS, Haniadka R, Pereira MM, D'Souza
JJ, Pallaty PL, Bhat HP and Popuri S: Update on the chemopreventive
effects of ginger and its phytochemicals. Crit Rev Food Sci Nutr.
51:499–523. 2011.PubMed/NCBI View Article : Google Scholar
|
17
|
Seo EY: Effects of (6)-gingerol, ginger
component on adipocyte development and differentiation in 3T3-L1. J
Nutr Heal. 48:327–334. 2015.
|
18
|
Tzeng TF, Chang CJ and Liu IM: 6-gingerol
inhibits rosiglitazone-induced adipogenesis in 3T3-L1 adipocytes.
Phyther Res. 28:187–192. 2014.PubMed/NCBI View
Article : Google Scholar
|
19
|
Li C and Zhou L: Inhibitory effect
6-gingerol on adipogenesis through activation of the Wnt/β-catenin
signaling pathway in 3T3-L1 adipocytes. Toxicol Vitr. 30:394–401.
2015.PubMed/NCBI View Article : Google Scholar
|
20
|
Cheng Z, Xiong X, Zhou Y, Wu F, Shao Q,
Dong R, Liu Q and Li L: 6-gingerol ameliorates metabolic disorders
by inhibiting hypertrophy and hyperplasia of adipocytes in
high-fat-diet induced obese mice. Biomed Pharmacother.
146(112491)2022.PubMed/NCBI View Article : Google Scholar
|
21
|
Park SH, Jung SJ, Choi EK, Ha KC, Baek HI,
Park YK, Han KH, Jeong SY, Oh JH, Cha YS, et al: The effects of
steamed ginger ethanolic extract on weight and body fat loss: a
randomized, double-blind, placebo-controlled clinical trial. Food
Sci Biotechnol. 29:265–273. 2020.PubMed/NCBI View Article : Google Scholar
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
23
|
Kim EJ, Kang MJ, Seo YB, Nam SW and Kim
GD: Acer okamotoanum nakai leaf extract inhibits adipogenesis via
suppressing expression of PPAR γ and C/EBP α in 3T3-L1 cells. J
Microbiol Biotechnol. 28:1645–1653. 2018.PubMed/NCBI View Article : Google Scholar
|
24
|
Oh MJ, Lee HHL, Lee HB, Do MH, Park M, Lee
CH and Park HY: A water soluble extract of radish greens
ameliorates high fat diet-induced obesity in mice and inhibits
adipogenesis in preadipocytes. Food Funct. 13:7494–7506.
2022.PubMed/NCBI View Article : Google Scholar
|
25
|
Palachai N, Wattanathorn J, Muchimapura S
and Thukham-Mee W: Antimetabolic syndrome effect of phytosome
containing the combined extracts of mulberry and ginger in an
animal model of metabolic syndrome. Oxid Med Cell Longev.
2019(5972575)2019.PubMed/NCBI View Article : Google Scholar
|
26
|
Pucci M, Mandrone M, Chiocchio I, Sweeney
EM, Tirelli E, Uberti D, Memo M, Poli F, Mastinu A and Abate G:
Different seasonal collections of Ficus carica L. Leaves diversely
modulate lipid metabolism and adipogenesis in 3T3-L1 adipocytes.
Nutrients. 14(2833)2022.PubMed/NCBI View Article : Google Scholar
|
27
|
Pei XD, He ZL, Yao HL, Xiao JS, Li L, Gu
JZ, Shi PZ, Wang JH and Jiang LH: 6-Shogaol from ginger shows
anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway.
Eur J Nutr. 60:2781–2793. 2021.PubMed/NCBI View Article : Google Scholar
|
28
|
de Lima RMT, Dos Reis AC, de Oliveira
Santos JV, de Oliveira Ferreira JR, Lima Braga A, de Oliveira Filho
JWG, de Menezes APM, da Mata AMOF, de Alencar MVOB, do Nascimento
Rodrigues DC, et al: Toxic, cytogenetic and antitumor evaluations
of (6)-gingerol in non-clinical in vitro studies. Biomed
Pharmacother. 115(108873)2019.PubMed/NCBI View Article : Google Scholar
|
29
|
Dugasani S, Pichika MR, Nadarajah VD,
Balijepalli MK, Tandra S and Korlakunta JN: Comparative antioxidant
and anti-inflammatory effects of (6)-gingerol, (8)-gingerol,
(10)-gingerol and (6)-shogaol. J Ethnopharmacol. 127:515–520.
2010.PubMed/NCBI View Article : Google Scholar
|
30
|
Qiu JL, Chai YN, Duan FY, Zhang HJ, Han
XY, Chen LY and Duan F: 6-Shogaol alleviates CCl4-induced liver
fibrosis by attenuating inflammatory response in mice through the
NF-κB pathway. Acta Biochim Pol. 69:363–370. 2022.PubMed/NCBI View Article : Google Scholar
|
31
|
Ebrahimzadeh Attari V, Malek Mahdavi A,
Javadivala Z, Mahluji S, Zununi Vahed S and Ostadrahimi A: A
systematic review of the anti-obesity and weight lowering effect of
ginger (Zingiber officinale Roscoe) and its mechanisms of
action. Phytother Res. 32:577–585. 2018.PubMed/NCBI View
Article : Google Scholar
|
32
|
Choi J, Kim KJ, Kim BH, Koh EJ, Seo MJ and
Lee BY: 6-gingerol suppresses adipocyte-derived mediators of
inflammation in vitro and in high-fat diet-induced obese zebra
fish. Planta Med. 83:245–253. 2017.PubMed/NCBI View Article : Google Scholar
|
33
|
Saravanan G, Ponmurugan P, Deepa MA and
Senthilkumar B: Anti-obesity action of gingerol: effect on lipid
profile, insulin, leptin, amylase and lipase in male obese rats
induced by a high-fat diet. J Sci Food Agric. 94:2972–2977.
2014.PubMed/NCBI View Article : Google Scholar
|
34
|
Jiao W, Mi S, Sang Y, Jin Q, Chitrakar B,
Wang X and Wang S: Integrated network pharmacology and cellular
assay for the investigation of an anti-obesity effect of 6-shogaol.
Food Chem. 374(131755)2022.PubMed/NCBI View Article : Google Scholar
|
35
|
Esteve Ràfols M: Adipose tissue: Cell
heterogeneity and functional diversity. Endocrinol Nutr.
61:100–112. 2014.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
36
|
Tzeng TF and Liu IM: 6-Gingerol prevents
adipogenesis and the accumulation of cytoplasmic lipid droplets in
3T3-L1 cells. Phytomedicine. 20:481–487. 2013.PubMed/NCBI View Article : Google Scholar
|
37
|
Uramaru N, Kawashima A, Osabe M and
Higuchi T: Rhododendrol, a reductive metabolite of raspberry
ketone, suppresses the differentiation of 3T3-L1 cells into
adipocytes. Mol Med Rep. 27:1–9. 2023.PubMed/NCBI View Article : Google Scholar
|
38
|
Smith A, Yu X and Yin L: Diazinon exposure
activated transcriptional factors CCAAT-enhancer-binding proteins α
(C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ)
and induced adipogenesis in 3T3-L1 preadipocytes. Pestic Biochem
Physiol. 150(48)2018.PubMed/NCBI View Article : Google Scholar
|
39
|
Kang MJ, Kim KK, Son BY, Nam SW, Shin PG
and Kim GD: The anti-adipogenic activity of a new cultivar,
pleurotus eryngii var. ferulae ‘beesan no. 2’, through
down-regulation of PPAR γ and C/EBP α in 3T3-L1 cells. J Microbiol
Biotechnol. 26:1836–1844. 2016.PubMed/NCBI View Article : Google Scholar
|
40
|
Zakłos-Szyda M, Pietrzyk N, Szustak M and
Podsędek A: Viburnum opulus L. juice phenolics inhibit mouse 3T3-L1
cells adipogenesis and pancreatic lipase activity. Nutrients.
12(2003)2020.PubMed/NCBI View Article : Google Scholar
|
41
|
Furuhashi M, Saitoh S, Shimamoto K and
Miura T: Fatty acid-binding protein 4 (FABP4): Pathophysiological
insights and potent clinical biomarker of metabolic and
cardiovascular diseases. Clin Med Insights Cardiol. 2014:23–33.
2014.PubMed/NCBI View Article : Google Scholar
|
42
|
Misawa K, Hashizume K, Yamamoto M,
Minegishi Y, Hase T and Shimotoyodome A: Ginger extract prevents
high-fat diet-induced obesity in mice via activation of the
peroxisome proliferator-activated receptor δ pathway. J Nutr
Biochem. 26:1058–1067. 2015.PubMed/NCBI View Article : Google Scholar
|
43
|
Okamoto M, Irii H, Tahara Y, Ishii H,
Hirao A, Udagawa H, Hiramoto M, Yasuda K, Takanishi A, Shibata S
and Shimizu I: Synthesis of a new (6)-gingerol analogue and its
protective effect with respect to the development of metabolic
syndrome in mice fed a high-fat diet. J Med Chem. 54:6295–6304.
2011.PubMed/NCBI View Article : Google Scholar
|
44
|
Impheng H, Richert L, Pekthong D,
Scholfield CN, Pongcharoen S, Pungpetchara I and Srisawang P:
(6)-Gingerol inhibits de novo fatty acid synthesis and carnitine
palmitoyltransferase-1 activity which triggers apoptosis in HepG2.
Am J Cancer Res. 5(1319)2015.PubMed/NCBI
|
45
|
Chirala SS and Wakil SJ: Structure and
function of animal fatty acid synthase. Lipids. 39:1045–1053.
2004.PubMed/NCBI View Article : Google Scholar
|
46
|
Batchuluun B, Pinkosky SL and Steinberg
GR: Lipogenesis inhibitors: Therapeutic opportunities and
challenges. Nat Rev Drug Discov. 21:283–305. 2022.PubMed/NCBI View Article : Google Scholar
|